NCT03233763

Laboratory Studies Into the Pathology of Leukaemia

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 500 (estimated)
• Sponsor: Royal Marsden NHS Foundation Trust · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Ongoing laboratory work into the pathology of Leukaemia:

Detailed description

The investigators will test AML samples sent to the diagnostic laboratory from participants with newly diagnosed or relapsed/refractory AML. Samples will be sent from district general hospitals and teaching hospitals. Results will be returned to referring clinicians in the same way investigators currently return results for samples sent for standard tests. The service will be advertised through the Royal Marsden Website with visibility to both participants and HCPs). The investigators will also inform all the clinicians involved in the AML working party (Dr Taussig is a member of the AML working group). In addition we are looking at diagnostic approaches to IDH 1 and 2 mutation identification. An initial comparison of 50 samples by three analysis methods will be conducted. IDH1 and IDH2 variant discovery will first be performed using an established standard in house SOP (SOP: SMD103) for CE-SSCA

Conditions

• Leukemia

Interventions

Type	Name	Description
PROCEDURE	Bone Marrow Aspirate	Diagnostic Bone Marrow aspirate

Timeline

• Start date: 2017-04-24
• Primary completion: 2021-02-01
• Completion: 2021-02-01
• First posted: 2017-07-31
• Last updated: 2017-07-31

Locations

1 site across 1 country: United Kingdom